Price to Book Value of DexCom

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Price to Book Value analysis of DexCom


 Price USD  335.20
 Book Value per share USD  9.69
 Capitalization (mn) USD  30,272
 Total Book Value (mn) USD  882
 P/BV ratio 34.60
 DexCom dividend
 DexCom Price to Cash-Flow
 DexCom Price to earnings
 DexCom Return on Equity

DexCom is a Health Care industry firm, which focus his business in Health Care Equipment and Services sector. DexCom offices are placed in USA, where the firm is traded.

At the date of this study, DexCom shares were being negotiated at a price of 335.20 USD after sky rocketing a 53.20% from the beginning of the year.

According to the chart displayed below, DexCom Price to Book Value Ratio is 34.60, bigger than the amount offered by both firms from USA and fromHealth Care Equipment and Services sector. This high P/BV might be a sign of a overvalued company, but also a healthy sign because the market expects growing profits in the near future for the same book value (originally invested). However, it is necessary to study DexCom financial situation to reach such a strong conclussion.

Finally, you could draw a comparisson DexCom P/BV with other Health Care Equipment and Services companies or firms from USA.

DexCom price to book value

Next companies

Dexus Property Group. Australia. Financials.

DGB Financial Group. Korea. Financials.

Diageo. UK. Consumer Goods.

Dialog Group. Malaysia. Oil and Gas.

Diamondback Energy. USA. Oil and Gas.

DiaSorin. Italy. Health Care.

Previous companies

Devon Energy. USA. Oil and Gas.

Deutsche Wohnen AG. Germany. Financials.

Deutsche Telekom. Germany. Telecommunications.

Deutsche Post. Germany. Industrials.

Deutsche Lufthansa A. Germany. Consumer Services.

Deutsche Boerse. Germany. Financials.

All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.